Literature DB >> 22682715

Predicting complicated choledocholithiasis.

Kristy L Kummerow1, Julia Shelton, Sharon Phillips, Michael D Holzman, William Nealon, William Beck, Kenneth Sharp, Benjamin K Poulose.   

Abstract

INTRODUCTION: Management of choledocholithiasis and its complications is variable and often requires transfer to a specialty facility. This study links patient-specific characteristics with the outcome measure of complicated choledocholithiasis to identify high-risk patients who may require expedited treatment or transfer to a higher level of care.
MATERIALS AND METHODS: Patients with a discharge diagnosis of choledocholithiasis (CDL) were identified from the 2009 Nationwide Inpatient Sample (NIS). Patient characteristics were identified associated with the primary outcome measure of complicated choledocholithiasis (cCDL), defined as acute pancreatitis or cholangitis during the admission for CDL. Predictors of mortality were also evaluated. Analysis was performed using complex-sample univariate and adjusted analyses.
RESULTS: We identified 123,990 discharges with a diagnosis of CDL. The overall incidence of CDL was 314 per 100,000 NIS discharges. Forty-one percent of CDL discharges were for cCDL (acute pancreatitis 31%, cholangitis 12%). Risk factors for cCDL included age (risk increased 0.8% per year), male gender (odds ratio [OR] 1.2, 95% confidence interval [CI] 1.1-1.2), alcohol abuse (OR 1.5, CI 1.3-1.8), diabetes (OR 1.1, CI 1.0-1.2), hypertension (OR 1.1, CI 1.0-1.2), obesity (OR 1.2, CI 1.1-1.3), nonelective admission (OR 2.3, CI 2.0-2.6), and Asian/Pacific Islander race/ethnicity (OR 1.2, CI 1.0-1.5). Patients with cCDL had increased odds of mortality (OR 1.5, CI 1.2-2.0).
CONCLUSIONS: Increased age, nonelective admission, and specific comorbid conditions are associated with cCDL, which has increased mortality. These factors can be used to identify patients needing timely access to treatment or transfer to a higher level of care.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22682715     DOI: 10.1016/j.jss.2012.04.034

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  What is the better surgical treatment option for recurrent common bile duct stones?

Authors:  Chi Young Park; Sung Hoon Choi; Chang-Il Kwon; Jae Hee Cho; Sung Ill Jang; Tae Hoon Lee; Joung-Ho Han; Seok Jeong; Kwang Hyun Ko
Journal:  Ann Surg Treat Res       Date:  2020-11-26       Impact factor: 1.859

2.  Epidemiology and disease characteristics of symptomatic choledocholithiasis in Sri Lanka.

Authors:  Waduthanthri Supun Lakmal De Silva; Ajith Aloka Pathirana; Thejana Kamil Wijerathne; Bawantha Dilshan Gamage; Buddhika Kemiya Dassanayake; Mohan Malith De Silva
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-02-28

3.  Factors and Outcomes Associated with MRCP Use prior to ERCP in Patients at High Risk for Choledocholithiasis.

Authors:  Gobind Anand; Yuval A Patel; Hsin-Chieh Yeh; Mouen A Khashab; Anne Marie Lennon; Eun Ji Shin; Marcia I Canto; Patrick I Okolo; Anthony N Kalloo; Vikesh K Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2016-04-28

4.  Primary Choledocholithiasis 15 Years Postcholecystectomy.

Authors:  Michael Simon; Irfan Nazir Hassan; Dhanasekaran Ramasamy; David Wilson
Journal:  Case Rep Med       Date:  2020-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.